Exchange: NASDAQ·Updated 04:10 PM EDT
BBOT logo

BBOT BridgeBio Oncology Therapeutics Inc.

$3.94
$0.16
(3.90%)
Today
Closed $3.94
$0.00
(0.00%)
After Hours
EarningsNov 11
Mkt Cap$328.71M
Vol1.36M

About BBOT

Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
39

Bearish Sentiment

How do you feel about BBOT?

Advertisement|Remove ads.